Skip to content

A study on the postoperative analgesic effect of liposomal bupivacaine combined with interscalene bupivacaine block in upper limb surgery

A study on the postoperative analgesic effect of liposomal bupivacaine combined with interscalene bupivacaine block in upper limb surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500108181
Enrollment
Unknown
Registered
2025-08-26
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder Injuries and Disorders

Interventions

Group A:Bupivacaine liposome 99.8mg for postoperative analgesia after interscaline brachial plexus block
Group B:Postoperative analgesia was achieved by interscaline brachial plexus block with bupivacaine liposome 79.8 mg and bupivacaine hydrochloride 2 0 mg

Sponsors

Liuzhou Worker's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Patients undergoing postoperative analgesia with nerve block; (2) Patients aged 18-60 years with a BMI between 18-27, with complete clinical records; (3) Patients with American Society of Anesthesiologists (ASA) anesthesia risk classification of I-III and cardiac function of I-II; (4) Patients scheduled for upper limb surgery under general anesthesia.

Exclusion criteria

Exclusion criteria: (1) Patients with a history of drug allergy; (2) Those with contraindications to anesthesia; (3) Those with severe heart, lung or brain diseases; (4) Those with impaired liver or kidney function; (5) Those with neurological or musculoskeletal disorders; (6) Those with poorly controlled diabetes; (7) Those with COPD or dysfunction of the opposite diaphragm.

Design outcomes

Primary

MeasureTime frame
Static and dynamic visual analogue scale (VAS) for pain simulation;

Countries

China

Contacts

Public ContactWu Donghai

Liuzhou Worker's Hospital

280382874@qq.com+86 136 4782 6605

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026